Yubico to Accelerate Passkey Adoption with Identity Verification Partnerships, Bolstering Defense Against AI-Driven Fraud
10.11.2025 15:00:00 CET | Business Wire | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO) – the creator of the most secure passkeys and leading provider of hardware authentication security keys – today announced two new collaborations with HYPR, the Identity Assurance Company and Nametag, the leader in workforce identity verification. As providers of modern Identity Verification (IDV), these partnerships will advance Yubico’s Bring Your Own IDV (BYOIDV) strategy, integrating verified identity into the secure provisioning, recovery, and lifecycle management of YubiKeys integrating with YubiKey as a Service.
“Yubico’s promise has always been trust made tangible, ensuring the person logging in is legitimate through hardware-based authentication,” said Albert Biketi, chief product and technology officer, Yubico. “By integrating IDV capabilities, we will extend this trust across the entire user lifecycle, from identity creation to login. This strengthens Yubico's commitment to helping organizations, governments, and individuals verify identities amidst increasing deepfakes, fraud, and AI deception.”
Addressing the Identity Trust Gap
In an era of sophisticated AI-driven impersonation and fraud, malicious actors are using stolen identities and fake documents to get hired and receive onboarding credentials, thereby gaining legitimate, high-trust access to corporate networks. Faced with these threats, IT and cybersecurity teams need new ways to establish and maintain trust in remote workforces. IDV solves the challenge of establishing trust in a remote or digital interaction by answering the critical question: "Is this person who they claim to be?"
Utilizing Identity Verification (IDV), Yubico’s market-leading secure enrollment ensures that every employee, contractor, or partner is confirmed before a YubiKey or PIN is issued or used, a critical step that strengthens defenses against sophisticated impersonation and AI fraud. These partnerships, initially with HYPR and Nametag, include the ability for customers to remotely verify the identity of employees before a YubiKey is issued or its PIN is ever activated. This helps enterprises guarantee every key is activated by the right person while significantly reducing IT friction. Where available globally, customers will be able to choose between HYPR Affirm or Nametag’s Deepfake Defense™ engine as their IDV provider.
"The combined strength of identity assurance and hardware security is unbeatable for securing remote access. HYPR is excited to partner with Yubico to deliver the essential Identity Assurance option that closes this crucial loop," said Bojan Simic, chief executive officer, HYPR. "By integrating HYPR's Zero Trust-enabling assurance framework directly into the YubiKey as a Service enrollment process, we guarantee that the industry's strongest security key is bound to a verified user and a trusted device, eliminating the risk of fraud during new hire onboarding and ensuring complete passwordless security from day one."
"Nametag is delighted to partner with Yubico, whose FIDO2 security keys are respected by security professionals and users alike," said Aaron Painter, chief executive officer, Nametag. "As the only provider of purpose-built, workforce-grade identity verification, Nametag is uniquely capable of proving that the person receiving and setting up a YubiKey is not just a real person, but the right person. This partnership with Yubico is a logical and exciting step for both companies.”
Customers can achieve top-tier, phishing-resistant security effortlessly thanks to the combined power of these solutions with YubiKey as a Service, the core benefits will include:
- Prevent Fraud: Stop bad actors who have made it through hiring checks from receiving legitimate authentication credentials during onboarding.
- Seamless Onboarding: A person's verified identity is anchored to their phishing-resistant passkey from Day 1, streamlining new user onboarding without adding undue friction.
- Reduce IT Burdens: Free up IT time spent on new employee onboarding by allowing users to benefit from secure self-service YubiKey credential enrollment.
- Ensure Compliance: Tying a person’s verified identity to their FIDO credential will give security teams a clear, auditable trail and automated proof of compliance.
By adding identity verification, YubiKey as a Service will strengthen onboarding security and create a foundational human layer for Zero Trust by ensuring every key is issued to a verified user. This evolution will help to ensure Yubico stays at the center of the new identity economy where identity verification, authentication and attestation form a unified security approach.
To stay updated on Yubico’s latest collaborations and developments with our IDV partners, please register here.
About Yubico
Yubico (Nasdaq Stockholm: YUBICO) is a modern cybersecurity company on a mission to make the internet safer for everyone. As the inventor of the YubiKey, we set the gold standard for modern phishing-resistant, hardware-backed authentication, stopping account takeovers and making secure login simple.
Since 2007, we’ve helped shape global authentication standards, co-created FIDO2, WebAuthn, and FIDO U2F, and introduced the original passkey. Today, our passkey technology secures people and organizations in over 160 countries—transforming how digital identity is protected from onboarding to account recovery.
Trusted by the world’s most security-conscious brands, governments, and institutions, YubiKeys work out of the box with hundreds of apps and services, delivering fast, passwordless access without friction or compromise.
We believe strong security should never be out of reach. Through our philanthropic initiative, Secure it Forward, we donate YubiKeys to nonprofits supporting at-risk communities.
Dual-headquartered in Stockholm, Sweden and Santa Clara, California, Yubico is proud to be recognized as one of TIME’s 100 Most Influential Companies and Fast Company’s Most Innovative Companies. Learn more at www.yubico.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251110464872/en/
Contacts
Yubico Communications Team
press@yubico.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom